China Resources Pharma (03320) has released the results of China Resources Pharmaceutical Holdings for the nine months ended September 30, 2026.
The company recorded operating revenue of RMB 203.528 billion, an increase of 1.32% year-on-year.
Net profit attributable to owners of the parent company was RMB 2.391 billion, a decrease of 6.73% year-on-year.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments